IFP Advisors’s Antares Pharma, Inc. ATRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-4,369
| Closed | -$12K | – | 4968 |
|
2022
Q3 | $12K | Hold |
4,369
| – | – | ﹤0.01% | 3541 |
|
2022
Q2 | $12K | Hold |
4,369
| – | – | ﹤0.01% | 3291 |
|
2022
Q1 | $12K | Buy |
4,369
+2,369
| +118% | +$6.51K | ﹤0.01% | 3291 |
|
2021
Q4 | $7K | Sell |
2,000
-1,715
| -46% | -$6K | ﹤0.01% | 2344 |
|
2021
Q3 | $13K | Buy |
3,715
+750
| +25% | +$2.62K | ﹤0.01% | 2130 |
|
2021
Q2 | $12K | Hold |
2,965
| – | – | ﹤0.01% | 2153 |
|
2021
Q1 | $12K | Buy |
2,965
+1,250
| +73% | +$5.06K | ﹤0.01% | 2069 |
|
2020
Q4 | $7K | Hold |
1,715
| – | – | ﹤0.01% | 2212 |
|
2020
Q3 | $5K | Hold |
1,715
| – | – | ﹤0.01% | 2196 |
|
2020
Q2 | $5K | Sell |
1,715
-3,000
| -64% | -$8.75K | ﹤0.01% | 2110 |
|
2020
Q1 | $11K | Hold |
4,715
| – | – | ﹤0.01% | 1732 |
|
2019
Q4 | $22K | Sell |
4,715
-28,000
| -86% | -$131K | ﹤0.01% | 1592 |
|
2019
Q3 | $111K | Buy |
+32,715
| New | +$111K | 0.01% | 1013 |
|
2019
Q1 | $0 | Sell |
95
-32,350
| -100% | – | ﹤0.01% | 3641 |
|
2018
Q4 | $85K | Sell |
32,445
-39,720
| -55% | -$104K | 0.01% | 1283 |
|
2018
Q3 | $242K | Buy |
72,165
+15,138
| +27% | +$50.8K | 0.01% | 976 |
|
2018
Q2 | $147K | Buy |
57,027
+56,932
| +59,928% | +$147K | 0.01% | 1244 |
|
2018
Q1 | $0 | Hold |
95
| – | – | ﹤0.01% | 3841 |
|
2017
Q4 | $0 | Sell |
95
-14,000
| -99% | – | ﹤0.01% | 4145 |
|
2017
Q3 | $46K | Hold |
14,095
| – | – | ﹤0.01% | 2028 |
|
2017
Q2 | $45K | Hold |
14,095
| – | – | ﹤0.01% | 2026 |
|
2017
Q1 | $40K | Hold |
14,095
| – | – | ﹤0.01% | 2044 |
|
2016
Q4 | $33K | Hold |
14,095
| – | – | ﹤0.01% | 2121 |
|
2016
Q3 | $24K | Hold |
14,095
| – | – | ﹤0.01% | 2292 |
|
2016
Q2 | $15K | Buy |
14,095
+14,000
| +14,737% | +$14.9K | ﹤0.01% | 2540 |
|
2016
Q1 | $0 | Sell |
95
-14,000
| -99% | – | ﹤0.01% | 3675 |
|
2015
Q4 | $17K | Buy |
+14,095
| New | +$17K | ﹤0.01% | 2260 |
|